Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial-Reference-Cited by-同舟云学术

Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial

Published:2021-10-06 Issue:5 Volume:39 Page:80-87
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Hatemi Gülen¹,Mahr Alfred²,Takeno Mitsuhiro³,Kim Do Young⁴,Saadoun David⁵,Direskeneli Haner⁶,Melikoğlu Melike⁷,Cheng Sue⁸,McCue Shannon⁸,Paris Maria⁸,Chen Mindy⁸,Yazici Yusuf⁹

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine and Behçet’s Disease Research Centre, Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, and Behçet’s Disease Research Centre, Istanbul, Turkey. gulenhatemi@yahoo.com

2. Clinic for Rheumatology, Cantonal Hospital St. Gallen, Switzerland.

3. Department of Allergy and Rheumatology, Nippon Medical School, Musahi Kosugi Hospital, Kawasaki, Japan.

4. Department of Dermatology, Yonsei University College of Medicine and Severance Hospital, Seoul, South Korea.

5. Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié Salpétrière, Paris, France.

6. Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.

7. Division of Rheumatology, Department of Internal Medicine and Behçet’s Disease Research Centre, Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, and Behçet’s Disease Research Centre, Istanbul, Turkey.

8. Clinical Development, Amgen Inc., Thousand Oaks, CA, USA.

9. Division of Rheumatology, New York University School of Medicine, NY, USA.

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newer Therapies in Rheumatology;Medical Clinics of North America;2024-09

2. Exploring relief for Behçet’s disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilast;Rheumatology;2024-05-30

3. Recomendaciones SER sobre el tratamiento del síndrome de Behçet refractario;Reumatología Clínica;2024-04

4. SER recommendations on treatment of refractory Behçet's syndrome;Reumatología Clínica (English Edition);2024-04

5. Behçet's syndrome;The Lancet;2024-03